Skip to contentA
Acro Biomedical Co., Ltd.
A
ACBMAcro Biomedical Co., Ltd. Q2 2019 · 10-Q
Revenue$0.00$0.00derivedno prior Q2 2018 on file Net Income-$50.82K-$50.82Kno prior Q2 2018 on file EPS Diluted$0.00$0.00no prior Q2 2018 on file The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
Operating Income-$68,092— Operating Cash Flowderived-$85,176— ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end